Wang C C
Am J Clin Oncol. 1985 Dec;8(6):512-6. doi: 10.1097/00000421-198512000-00011.
This paper presents the results of treatment on 99 patients with squamous cell carcinoma of the oropharynx irradiated by the twice-a-day radiation therapy program at the Massachusetts General Hospital. The program consisted of 1.6 Gy per fraction, two fractions per day with 4 hours between fractions, for 12 days, 5 days a week. After 38.4 Gy, the patients were given a 2 week break and then resumed twice-a-day radiation therapy for a total of 64 Gy and occasionally 67.2 Gy. Fifty-two patients had carcinoma of the faucial tonsil and 47 patients had carcinoma of the base of the tongue. For the entire group of patients, the 36 month actuarial local control rate was 58%, and for the T1-2 and T3-4 lesions, the rates were 77% and 48% respectively. In comparison with patients treated by once-a-day radiation therapy for a few years immediately prior to the twice-a-day program, the local control rates were improved to a statistically significant level. Likewise, the results as compared to those published in the literature were no worse and perhaps superior to those of patients treated by the once-a-day schedule.
本文介绍了麻省总医院采用每日两次放疗方案对99例口咽鳞状细胞癌患者进行治疗的结果。该方案为每次分割剂量1.6Gy,每天两次,两次分割之间间隔4小时,共照射12天,每周5天。照射38.4Gy后,患者休息2周,然后继续每日两次放疗,总量达64Gy,偶尔为67.2Gy。52例患者为扁桃体癌,47例患者为舌根癌。对于整个患者组,36个月的精算局部控制率为58%,T1 - 2和T3 - 4病变的控制率分别为77%和48%。与在每日两次放疗方案实施前几年采用每日一次放疗方案治疗的患者相比,局部控制率提高到了具有统计学意义的水平。同样,与文献中发表的结果相比,该结果并不更差,甚至可能优于采用每日一次放疗方案治疗的患者。